Related Experiment Video
Updated: Jan 5, 2026
09:53
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
4.1K
Clinical outcomes in primary scalp angiosarcoma.
Yong Zhang1, Yanwen Yan1, Ming Zhu1
1Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Oncology Letters
|October 16, 2019
Summary
Scalp angiosarcoma, a rare aggressive cancer, has poor survival rates. Localized nodular lesions and younger age (<70) show better outcomes, but overall prognosis remains poor.
Area of Science:
- Oncology
- Dermatology
- Surgical Pathology
Background:
- Scalp angiosarcoma is an extremely rare and aggressive skin cancer.
- It is associated with a poor patient prognosis.
Purpose of the Study:
- To analyze clinical characteristics, treatment, and outcomes of scalp angiosarcoma patients.
- To determine factors influencing overall survival (OS) and recurrence-free survival (RFS).
Main Methods:
- Retrospective review of 42 scalp angiosarcoma cases treated between 2002-2013.
- Analysis of demographics, treatment regimens (surgery, chemotherapy, radiotherapy), and survival data.
- Calculation of 5-year OS and RFS rates.
Main Results:
- The 5-year OS rate was 19% and the 5-year RFS rate was 10%.
- Nodular localized lesions significantly improved OS (P=0.0078).
- Patients aged ≥70 had lower OS (P=0.0071) and RFS (P=0.0095) compared to younger patients.
Conclusions:
- Tumor presentation as nodular localized lesions indicates a better prognosis than diffuse lesions.
- While younger patients fare better, high recurrence and mortality rates persist for all.
- Current treatment strategies did not show significant association with improved OS or RFS.
